Hypertension (high blood pressure) decisions — 2025

The Board granted service connection for the cause of the Veteran's death due to mycosis fungoides cutaneous T, T cell lymphoma and hypertension, which was presumed connected to his exposure to herbicide agents during active service in Vietnam.

The Board denied increased ratings for hypertension, PTSD with MDD and insomnia disorder, tinnitus, right ear hearing loss, eczematous dermatitis of the wrists and feet, and DDD, L5-S1, with retrolisthesis. TDIU was granted as of September 22, 2015.

The Board granted service connection for hypertension under the PACT Act and remanded the claim for trigeminal neuralgia due to a need for additional evidence.

The Board denied the Veteran's claims for a rating higher than 10 percent for hypertension and service connection for headaches.

The Board denied service connection for prostate cancer, hypertension, and a gallbladder disability as there is no evidence of current disabilities at any time during or approximate to the pendency of the claims.

The Board denied an initial rating higher than 10 percent for hypertension and remanded the claims for service connection for bile duct cancer and a TDIU prior to August 23, 2024.

The Board denied the Veteran's claims for service connection for hypertension and temporomandibular joint disorder (TJD) as there was no current diagnosis of either condition during or approximate to the claims period on appeal.

The Board granted service connection for hypertension (HTN) and remanded the claims for a heart condition, skin condition, left knee disability, and right knee disability.

The Board denied service connection for parkinsonism, hypertension, and diabetes mellitus type II. The claims for ischemic heart disease status post pacemaker and status post pacemaker were remanded.

The Board granted service connection for bilateral hearing loss, right and left knee disabilities, tinnitus, and hypertension. Type 2 diabetes mellitus was denied, as were claims for obstructive sleep apnea (OSA) and gout. Rheumatoid arthritis and a back disability are also being remanded.

The Board granted service connection for hypertension, as due to in-service exposure to radiation under the PACT Act, but denied service connection for diabetes mellitus.

The Veteran's claims for special monthly compensation based on the need for aid and attendance, loss of use of a creative organ, and service connection for erectile dysfunction as secondary to his service-connected conditions have been granted.

The Board denied service connection for obstructive sleep apnea, insomnia, diabetes mellitus, type II, a kidney disability, an eye disability, bilateral lower extremities peripheral neuropathy, and bilateral upper extremities peripheral neuropathy as there was no evidence of an in-service injury or incurrence related to these conditions. The claims for service connection for bilateral hearing loss, arthritis, hypertension, headaches, and tinnitus were remanded for further development.

The Board granted service connection for a heart disorder, diagnosed as hypertension, finding it to be proximately due to the Veteran's service-connected severe sleep apnea.

The Board remands the claims for a higher rating for bilateral equinus deformity with arthritis, an initial compensable rating for hypertension, and service connection for PTSD, anxiety and depression due to insufficient evidence.

The Board denied service connection for right knee osteoarthritis, left knee osteoarthritis, and hypertension. The claim for obstructive sleep apnea was remanded.

The Board remands the claims for service connection for hypertension, chronic kidney disease, and multiple myeloma due to a failure to properly develop the record.

The Board remands the veteran's claims for service connection due to outstanding records and the need for VA examinations.

The Board granted the appeals, restoring service connection for ischemic heart disease, supraventricular arrhythmia, and hypertension, and granting service connection for prostate cancer.

The Board denied the veteran's claims for a compensable evaluation prior to October 31, 2022, and an increased rating from that date for hypertension, as well as service connection for multiple myeloma cancer.